Hybrid EventIn-person & Virtual
March 18–20, 2027|Singapore · Village Hotel Changi

11th Edition of Global Congress on

Plant Biology and Biotechnology

March 18–20, 2027 Singapore Hybrid Event
Session Track · GPB 2027

Plant Based Pharmaceuticals at GPB 2027

Part of the GPB 2027 scientific programme · Village Hotel Changi, Singapore · March 18–20, 2027

About the Plant Based Pharmaceuticals Session

Plant-based pharmaceuticals, also known as phytomedicines or phytopharmaceuticals, represent a burgeoning field at the intersection of traditional herbal medicine and modern pharmaceuticals. These medicines are derived from botanical sources, harnessing the therapeutic properties of various plant compounds to prevent, treat, or manage diseases. With a rich history spanning centuries across diverse cultures, plant-based pharmaceuticals offer a treasure trove of bioactive compounds, including alkaloids, flavonoids, terpenoids, and polyphenols, which exhibit a wide array of pharmacological effects. Advancements in technology, such as extraction techniques, bioassay-guided fractionation, and phytochemical profiling, have facilitated the identification, isolation, and standardization of these active compounds, enhancing their efficacy and safety profiles. From aspirin derived from willow bark to the cancer-fighting properties of the Madagascar periwinkle, numerous plant-derived drugs have made significant contributions to modern medicine. Moreover, the growing demand for natural and sustainable healthcare options, coupled with concerns regarding synthetic drug side effects and environmental impact, has fueled the resurgence of interest in plant-based therapies. This resurgence is evident in the development of novel plant-derived drugs for various ailments, including cardiovascular diseases, cancer, diabetes, neurodegenerative disorders, and infectious diseases. Additionally, botanical supplements and nutraceuticals, ranging from turmeric extracts to ginseng capsules, have gained popularity as adjunctive therapies for promoting general health and well-being. However, challenges such as standardization, quality control, bioavailability, and regulatory frameworks persist in the development and commercialization of plant-based pharmaceuticals. Despite these challenges, the integration of traditional herbal knowledge with modern scientific methodologies holds immense promise for the discovery and development of safer, more effective, and sustainable therapeutic interventions, ushering in a new era of plant-powered medicine.

Topics Covered in Plant Based Pharmaceuticals

Topic 01

Plant-derived active pharmaceutical ingredients

Topic 02

Molecular farming of biopharmaceuticals

Topic 03

Expression platforms in plants

Topic 04

Extraction and purification of drugs

Topic 05

Preclinical and clinical evaluation

Topic 06

Good manufacturing practice and regulation

Featured Speakers — Plant Based Pharmaceuticals 2027

Speaker lineup for this track will be announced soon.

Browse all speakers →

Recent Research Presented at Plant Based Pharmaceuticals Sessions

Selected abstracts from this track will be published here.

Related Scientific Sessions at GPB 2027

Why Attend the Plant Based Pharmaceuticals Conference 2027

Earn CPD Credit

Sessions are CPD-accredited — earn 1 CPD credit for each hour of attendance.

Present Your Research

Oral and poster slots for original Plant Based Pharmaceuticals work, reviewed by the scientific committee.

Network Globally

Meet plant scientists, breeders, biotechnologists and crop researchers from around the world across three days.

Featured in the Abstract Book

Accepted abstracts are collected in the conference abstract book, published for every edition.

Learn from Keynotes

Plenary lectures from leading voices shaping Plant Based Pharmaceuticals research and practice.

Hybrid Flexibility

Attend in person in Singapore or join virtually — same programme, same certificate.

Join GPB 2027 for the Plant Based Pharmaceuticals track

Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.

Plant Based Pharmaceuticals Conference 2027 — FAQs

What is the Plant Based Pharmaceuticals track at GPB 2027?

The Plant Based Pharmaceuticals track is a dedicated stream within GPB 2027 covering the latest research, clinical innovation, and best practice in Plant Based Pharmaceuticals. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.

Who should attend the Plant Based Pharmaceuticals sessions?

Plant scientists, breeders, biotechnologists, agronomists, doctoral students, and research leaders with an interest in Plant Based Pharmaceuticals are all welcome — whether presenting or attending.

Can I present my research in the Plant Based Pharmaceuticals track?

Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.

Is virtual attendance available for Plant Based Pharmaceuticals sessions?

Yes. GPB 2027 is a hybrid conference — attend the Plant Based Pharmaceuticals track in person in Singapore or join live online, with on-demand access afterward.

Join the GPB 2027 delegation

Singapore · March 18–20, 2027· Hybrid · in-person & virtual

Register as Delegate →

Attend without presenting.

Chat with us